Table I.
MAbs | Competitors
|
|||
---|---|---|---|---|
CD4Ig | VRC01 | 17b | ||
Rabbit MAbs | 25-11 | ++ | +++ | − |
30-9 | ++ | +++ | − | |
41-7 | ++ | ++ | − | |
46-1 | ++ | +++ | − | |
57-5 | ++ | ++ | − | |
58-2 | ++ | ++ | − | |
78-4 | ++ | +++ | − | |
| ||||
CD4bs MAbs | VRC01 | +++ | +++ | Enhance* |
b12 | +++ | +++ | + | |
F105 | +++ | +++ | +++ | |
GE125 | +++ | +++ | ++ | |
GE136 | +++ | +++ | ++ | |
GE140 | +++ | +++ | ++ | |
| ||||
V3 MAb | 447 | − | − | − |
+++, 75–100% competition; ++, 50–75% competition; +, 25–50 competition; −, < 25% competiti on.
17b enhanced VRC01 binding more than 30%.